TLK-286
- PMID: 15334311
TLK-286
Abstract
Telik Inc is developing TLK-286, a modified glutathione analog prodrug, for the potential treatment of cancer.
Telik Inc is developing TLK-286, a modified glutathione analog prodrug, for the potential treatment of cancer.